Apsis Aerocom Ltd(APSISAERO)

NSE: APSISAERO

₹ 642.95+2.59%refreshed 13 Oct, 03:30 pm ISTMarket cap: ₹ 775 crWebsite: apsisaerocom.com/Updated: 26 Oct 2026

About

Apsis Aerocom is a Bengaluru-based precision engineering company. It makes components to customer specifications and provides allied services for the aerospace, defence and healthcare industries. Revenue was 30.65 in FY26. Defence was the largest segment that year, at ₹2,008.31 lakhs of ₹3,064.52 lakhs revenue from operations.^[1][2][3]

Business segments

Defence: revenue of ₹2,008.31 lakhs in FY26 vs ₹929.49 lakhs in FY25, out of total revenue from operations of ₹3,064.52 lakhs vs ₹2,049.06 lakhs.^[3]
Aerospace: revenue of ₹785.57 lakhs in FY26 vs ₹616.95 lakhs in FY25.^[3]
Healthcare: revenue of ₹235.73 lakhs in FY26 vs ₹457.95 lakhs in FY25.^[3]

Products and capabilities

Makes precision components and provides allied services for aerospace, defence and healthcare customers (FY26).^[1]
Each product is customised to the customer's specifications and made only against confirmed orders.^[1]
In-house capabilities cover CAD design migration, prototyping, tooling, surface finishing, quality assurance, assembly and dispatch.^[1]
Quality systems are aligned with AS9100D and ISO 9001:2015, and the company reports an aggregate accuracy rate of about 99.99% (FY26 annual report).^[1]

Manufacturing capacity

The FY26 annual report puts Unit I's annual installed capacity at about 1,50,000 components, with average utilisation of around 82%.^[1]
The Q4 FY26 earnings call gives Unit I's installed capacity as 1,20,000 components p.a. for FY26.^[3]
Unit II is at the Hitech Defence and Aerospace Park in Yelahanka, Bengaluru, with a built-up area of about 20,000 sq. ft.^[1]

Order book

Open order book of ₹40.50 cr as of FY26, about 1.3x FY26 revenue: defence ₹25.33 cr, aerospace ₹12.90 cr, healthcare ₹1.60 cr, others ₹0.67 cr.^[3]
Defence made up 62% and aerospace 32% of the FY26 open order book.^[3]

Customers and markets

Customers are domestic and international OEMs in aerospace, defence and healthcare. The company sells directly, without dealers or distributors.^[1]
Most revenue comes from the domestic market. The company also serves customers in the United States, Spain and Israel.^[1]
The top customer made up 35.59% of revenue in FY26 vs 52.03% in FY25. In FY26 the top 3, 5 and 10 customers made up 77.31%, 87.37% and 96.97%; the top 3 made up 84.04% in FY25.^[3]

Expansion and capex

Unit II: ₹27.02 cr capex for 34 machines and equipment, funded by IPO proceeds, adding about 1,80,000 components p.a. of installed capacity.^[3]
The FY26 annual report lists commissioning and ramping up Unit II as a goal.^[1]
Unit III: KIADB has issued an allotment letter for a 40,000 sq ft land parcel in Devanahalli Industrial Area, Bengaluru, for a new plant. The transfer is subject to conditions.^[3]
The company plans to move its core business processes to SAP ERP during FY27.^[1]

Recent developments

16 Sep 2026: won a domestic supply order worth INR 4,29,68,670 from a local healthcare customer, to be executed within 7 months.^[4]
Listed on NSE Emerge through an IPO of 32,52,000 equity shares at ₹110 each (FY26).^[1]

Market Cap

₹775 Cr

High / Low

₹643 / 147

Stock P/E

95.8

Price / Book

0.0

Book Value

₹41

EPS

₹6.2

No. of Shares

1.21 Cr

ROCE

19.9%

ROE

15.4%

OPM

34.4%

Debt / Equity

0.09

Sales

₹31 Cr

Net Profit

₹8 Cr

Promoter holding

73.0%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials